SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-181304
Filing Date
2010-08-06
Accepted
2010-08-06 15:49:50
Documents
7
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 413411
2 WAIVER OF RIGHTS UPON ISSUANCE OF OTHER SECURITIES dex41.htm EX-4.1 8088
3 LANDLORD, SUBLESSOR AND SUBLESSEE AGREEMENT dex101.htm EX-10.1 24268
4 SUBLEASE AGREEMENT BY AND BETWEEN ANTIGENICS INC. AND CUBIST PHARMACEUTICALS dex102.htm EX-10.2 69495
5 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9466
6 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9740
7 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 4735
  Complete submission text file 0001193125-10-181304.txt   540616
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 10998344
SIC: 2836 Biological Products, (No Diagnostic Substances)